<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN">
<html>
<head>
<meta content="text/html; charset=ISO-8859-1"
http-equiv="Content-Type">
</head>
<body text="#000000" bgcolor="#ffffff">
Hi Mark,<br>
<br>
Both Apache services were installed and stopped before starting the
corosync service.<br>
I have researched the resource agents sources and I'm getting
suspicious that in Debian<br>
preconfigured Apache and Pacemaker installation, there may be an
issue with ocf:heartbeat:apache<br>
agent. I will read the sources more carefully and I would like some
help to setup the environment<br>
exactly like the one Pacemaker uses when he tries to run the agent.
This would give me some <br>
more detailed output to debug the problem. Thanks for the replies.<br>
<br>
On 10/01/2011 07:05 PM, mark - pacemaker list wrote:
<blockquote
cite="mid:CAP31a4A2XfigQz3EhAHjMpe8G6xVnHsT5jpL5uPZ0nGHyUo=Jw@mail.gmail.com"
type="cite"><br>
<br>
<div class="gmail_quote">On Sat, Oct 1, 2011 at 5:32 AM, Miltiadis
Koutsokeras <span dir="ltr"><<a moz-do-not-send="true"
href="mailto:m.koutsokeras@biovista.com">m.koutsokeras@biovista.com</a>></span>
wrote:<br>
<blockquote class="gmail_quote" style="margin: 0pt 0pt 0pt
0.8ex; border-left: 1px solid rgb(204, 204, 204);
padding-left: 1ex;">
From the<br>
messages it seems like the manager is getting unexpected exit
codes from the<br>
Apache resource. The server-status URL is accessible from
127.0.0.1 in both nodes.<br>
<br>
</blockquote>
<div><br>
</div>
<div>Am I understanding correctly that Apache is already running
prior to your starting corosync/pacemaker? You'll want to
disable apache starting external to pacemaker, let the
resource agent start it. You say it's accessible from
loopback and you attached output of server-status, although
your crm_mon output clearly shows that it hasn't successfully
started the Apache2 resource. When pacemaker is started,
apache shouldn't be running on either node.</div>
<div><br>
</div>
<div>Sorry if I'm misunderstanding the scenario, though.</div>
<div><br>
</div>
<div>Regards,</div>
<div>Mark</div>
</div>
<pre wrap="">
<fieldset class="mimeAttachmentHeader"></fieldset>
_______________________________________________
Pacemaker mailing list: <a class="moz-txt-link-abbreviated" href="mailto:Pacemaker@oss.clusterlabs.org">Pacemaker@oss.clusterlabs.org</a>
<a class="moz-txt-link-freetext" href="http://oss.clusterlabs.org/mailman/listinfo/pacemaker">http://oss.clusterlabs.org/mailman/listinfo/pacemaker</a>
Project Home: <a class="moz-txt-link-freetext" href="http://www.clusterlabs.org">http://www.clusterlabs.org</a>
Getting started: <a class="moz-txt-link-freetext" href="http://www.clusterlabs.org/doc/Cluster_from_Scratch.pdf">http://www.clusterlabs.org/doc/Cluster_from_Scratch.pdf</a>
Bugs: <a class="moz-txt-link-freetext" href="http://developerbugs.linux-foundation.org/enter_bug.cgi?product=Pacemaker">http://developerbugs.linux-foundation.org/enter_bug.cgi?product=Pacemaker</a>
</pre>
</blockquote>
<br>
<br>
<pre class="moz-signature" cols="72">--
Koutsokeras Miltiadis M.Sc.
Software Engineer
Biovista Inc.
US Offices
2421 Ivy Road
Charlottesville, VA 22903
USA
T: +1.434.971.1141
F: +1.434.971.1144
European Offices
34 Rodopoleos Street
Ellinikon, Athens 16777
GREECE
T: +30.210.9629848
F: +30.210.9647606
<a class="moz-txt-link-abbreviated" href="http://www.biovista.com">www.biovista.com</a>
Biovista is a privately held biotechnology company that finds novel uses for existing drugs, and profiles their side effects using their mechanism of action. Biovista develops its own pipeline of drugs in CNS, oncology, auto-immune and rare diseases. Biovista is collaborating with biopharmaceutical companies on indication expansion and de-risking of their portfolios and with the FDA on adverse event prediction.
</pre>
</body>
</html>